Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.90 is 33% below its 5-year average of 14.73, near the low end of its 5-year range (7.69–25.41).
As of the fiscal period ended Tuesday, June 30, 2026. 24.69% below its 12-month average of 13.14.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.90.
CURRENT RATIO
9.90
CURRENT RATIO AVG TTM
13.14
CURRENT RATIO AVG 3Y
14.22
CURRENT RATIO AVG 5Y
14.73
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.69%
CURRENT VS 3Y AVG
-30.41%
CURRENT VS 5Y AVG
-32.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+163.92%
vs the sector median at left
Pliant Therapeutics, Inc.
Market Cap
$62.85M
Current Ratio
9.90
TTM Avg
13.14
3Y Avg
14.22
5Y Avg
14.73
Market Cap
$63.41M
Current Ratio
2.49
TTM Avg
2.38
3Y Avg
2.41
5Y Avg
2.71
Market Cap
$60.68M
Current Ratio
10.98
TTM Avg
17.43
3Y Avg
9.10
5Y Avg
12.08
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pliant Therapeutics, Inc. (PLRX) | $62.85M | 9.90 | 13.14 | 14.22 | 14.73 |
| RenovoRx, Inc. (RNXT)vs › | $63.07M | 5.74 | 4.06 | 3.99 | 5.63 |
| Alps Group Inc (ALPS)vs › | $63.23M | 0.36 | 0.31 | 0.29 | 1.05 |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.41M | 2.49 | 2.38 | 2.41 | 2.71 |
| InterCure Ltd. (INCR)vs › | $63.64M | 1.48 | 1.60 | 1.69 | 1.84 |
| Gossamer Bio, Inc. (GOSS)vs › | $64.83M | 0.53 | 4.76 | 5.20 | 7.10 |
| Kalaris Therapeutics Inc (KLRS)vs › | $60.68M | 10.98 | 17.43 | 9.10 | 12.08 |
| Fractyl Health, Inc. (GUTS)vs › | $61.67M | 3.15 | 4.21 | 4.67 | 4.26 |
| Xilio Therapeutics, Inc. (XLO)vs › | $60.89M | 4.25 | 2.40 | 3.43 | 5.08 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | 1.35 | 1.97 | 5.50 | 8.52 |
Current Ratio
9.90
Quick Ratio
9.90
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.90 |
| 2026-03-31 | 16.89 |
| 2025-12-31 | 12.00 |
| 2025-09-30 | 13.93 |
| 2025-06-30 | 12.99 |
| 2025-03-31 | 11.03 |
| 2024-12-31 | 10.91 |
| 2024-09-30 | 10.26 |
| 2024-06-30 | 14.47 |
| 2024-03-31 | 16.12 |
| 2023-12-31 | 17.72 |
| 2023-09-30 | 19.50 |
| 2023-06-30 | 19.16 |
| 2023-03-31 | 25.41 |
| 2022-12-31 | 14.23 |
| 2022-09-30 | 13.99 |
| 2022-06-30 | 7.69 |
| 2022-03-31 | 10.12 |
| 2021-12-31 | 12.44 |
| 2021-09-30 | 17.69 |
| 2021-06-30 | 22.93 |
| 2021-03-31 | 26.39 |
| 2020-12-31 | 25.07 |
| 2020-09-30 | 27.91 |
| 2020-06-30 | 26.95 |
| 2020-03-31 | 18.41 |
| 2019-12-31 | 13.69 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 6.20 |
| 2018-03-31 | 0.00 |
